NEW YORK (GenomeWeb News) – Denator and two Dutch medical centers today announced a collaboration to develop a biomarker discovery platform for the diagnosis of cancer.

Denator, based in Gothenburg, Sweden, is working with Erasmus Medical Center and Amsterdam Medical Center to develop and verify a prototype platform for monitoring specific protein and peptide degradation patterns in biological fluids and tissue sections. Denator is applying its heat stabilization technology to the project, which is being funded by the EU Eurostars program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.